Copyright Reports & Markets. All rights reserved.

Global Herpes Zoster Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Herpes Zoster Treatment
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Herpes Zoster Treatment by Type
    • 1.3.1 Overview: Global Herpes Zoster Treatment Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Herpes Zoster Treatment Consumption Value Market Share by Type in 2023
    • 1.3.3 Oral
    • 1.3.4 Topical
    • 1.3.5 Others
  • 1.4 Global Herpes Zoster Treatment Market by Application
    • 1.4.1 Overview: Global Herpes Zoster Treatment Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospitals
    • 1.4.3 Clinics
    • 1.4.4 Home Care Settings
  • 1.5 Global Herpes Zoster Treatment Market Size & Forecast
  • 1.6 Global Herpes Zoster Treatment Market Size and Forecast by Region
    • 1.6.1 Global Herpes Zoster Treatment Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Herpes Zoster Treatment Market Size by Region, (2019-2030)
    • 1.6.3 North America Herpes Zoster Treatment Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Herpes Zoster Treatment Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Herpes Zoster Treatment Market Size and Prospect (2019-2030)
    • 1.6.6 South America Herpes Zoster Treatment Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Herpes Zoster Treatment Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Roche
    • 2.1.1 Roche Details
    • 2.1.2 Roche Major Business
    • 2.1.3 Roche Herpes Zoster Treatment Product and Solutions
    • 2.1.4 Roche Herpes Zoster Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Roche Recent Developments and Future Plans
  • 2.2 Novartis
    • 2.2.1 Novartis Details
    • 2.2.2 Novartis Major Business
    • 2.2.3 Novartis Herpes Zoster Treatment Product and Solutions
    • 2.2.4 Novartis Herpes Zoster Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Novartis Recent Developments and Future Plans
  • 2.3 Merck
    • 2.3.1 Merck Details
    • 2.3.2 Merck Major Business
    • 2.3.3 Merck Herpes Zoster Treatment Product and Solutions
    • 2.3.4 Merck Herpes Zoster Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Merck Recent Developments and Future Plans
  • 2.4 GlaxoSmithKline
    • 2.4.1 GlaxoSmithKline Details
    • 2.4.2 GlaxoSmithKline Major Business
    • 2.4.3 GlaxoSmithKline Herpes Zoster Treatment Product and Solutions
    • 2.4.4 GlaxoSmithKline Herpes Zoster Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 GlaxoSmithKline Recent Developments and Future Plans
  • 2.5 Abbott Laboratories
    • 2.5.1 Abbott Laboratories Details
    • 2.5.2 Abbott Laboratories Major Business
    • 2.5.3 Abbott Laboratories Herpes Zoster Treatment Product and Solutions
    • 2.5.4 Abbott Laboratories Herpes Zoster Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Abbott Laboratories Recent Developments and Future Plans
  • 2.6 Astellas Pharma
    • 2.6.1 Astellas Pharma Details
    • 2.6.2 Astellas Pharma Major Business
    • 2.6.3 Astellas Pharma Herpes Zoster Treatment Product and Solutions
    • 2.6.4 Astellas Pharma Herpes Zoster Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Astellas Pharma Recent Developments and Future Plans
  • 2.7 Bausch Health Companies
    • 2.7.1 Bausch Health Companies Details
    • 2.7.2 Bausch Health Companies Major Business
    • 2.7.3 Bausch Health Companies Herpes Zoster Treatment Product and Solutions
    • 2.7.4 Bausch Health Companies Herpes Zoster Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Bausch Health Companies Recent Developments and Future Plans
  • 2.8 Teva Pharmaceutical
    • 2.8.1 Teva Pharmaceutical Details
    • 2.8.2 Teva Pharmaceutical Major Business
    • 2.8.3 Teva Pharmaceutical Herpes Zoster Treatment Product and Solutions
    • 2.8.4 Teva Pharmaceutical Herpes Zoster Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Teva Pharmaceutical Recent Developments and Future Plans
  • 2.9 Foamix Pharmaceuticals
    • 2.9.1 Foamix Pharmaceuticals Details
    • 2.9.2 Foamix Pharmaceuticals Major Business
    • 2.9.3 Foamix Pharmaceuticals Herpes Zoster Treatment Product and Solutions
    • 2.9.4 Foamix Pharmaceuticals Herpes Zoster Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Foamix Pharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Herpes Zoster Treatment Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Herpes Zoster Treatment by Company Revenue
    • 3.2.2 Top 3 Herpes Zoster Treatment Players Market Share in 2023
    • 3.2.3 Top 6 Herpes Zoster Treatment Players Market Share in 2023
  • 3.3 Herpes Zoster Treatment Market: Overall Company Footprint Analysis
    • 3.3.1 Herpes Zoster Treatment Market: Region Footprint
    • 3.3.2 Herpes Zoster Treatment Market: Company Product Type Footprint
    • 3.3.3 Herpes Zoster Treatment Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Herpes Zoster Treatment Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Herpes Zoster Treatment Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Herpes Zoster Treatment Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Herpes Zoster Treatment Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Herpes Zoster Treatment Consumption Value by Type (2019-2030)
  • 6.2 North America Herpes Zoster Treatment Consumption Value by Application (2019-2030)
  • 6.3 North America Herpes Zoster Treatment Market Size by Country
    • 6.3.1 North America Herpes Zoster Treatment Consumption Value by Country (2019-2030)
    • 6.3.2 United States Herpes Zoster Treatment Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Herpes Zoster Treatment Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Herpes Zoster Treatment Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Herpes Zoster Treatment Consumption Value by Type (2019-2030)
  • 7.2 Europe Herpes Zoster Treatment Consumption Value by Application (2019-2030)
  • 7.3 Europe Herpes Zoster Treatment Market Size by Country
    • 7.3.1 Europe Herpes Zoster Treatment Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Herpes Zoster Treatment Market Size and Forecast (2019-2030)
    • 7.3.3 France Herpes Zoster Treatment Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Herpes Zoster Treatment Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Herpes Zoster Treatment Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Herpes Zoster Treatment Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Herpes Zoster Treatment Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Herpes Zoster Treatment Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Herpes Zoster Treatment Market Size by Region
    • 8.3.1 Asia-Pacific Herpes Zoster Treatment Consumption Value by Region (2019-2030)
    • 8.3.2 China Herpes Zoster Treatment Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Herpes Zoster Treatment Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Herpes Zoster Treatment Market Size and Forecast (2019-2030)
    • 8.3.5 India Herpes Zoster Treatment Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Herpes Zoster Treatment Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Herpes Zoster Treatment Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Herpes Zoster Treatment Consumption Value by Type (2019-2030)
  • 9.2 South America Herpes Zoster Treatment Consumption Value by Application (2019-2030)
  • 9.3 South America Herpes Zoster Treatment Market Size by Country
    • 9.3.1 South America Herpes Zoster Treatment Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Herpes Zoster Treatment Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Herpes Zoster Treatment Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Herpes Zoster Treatment Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Herpes Zoster Treatment Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Herpes Zoster Treatment Market Size by Country
    • 10.3.1 Middle East & Africa Herpes Zoster Treatment Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Herpes Zoster Treatment Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Herpes Zoster Treatment Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Herpes Zoster Treatment Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Herpes Zoster Treatment Market Drivers
  • 11.2 Herpes Zoster Treatment Market Restraints
  • 11.3 Herpes Zoster Treatment Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Herpes Zoster Treatment Industry Chain
  • 12.2 Herpes Zoster Treatment Upstream Analysis
  • 12.3 Herpes Zoster Treatment Midstream Analysis
  • 12.4 Herpes Zoster Treatment Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Herpes Zoster Treatment market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
    Herpes Zoster, also known as zoster or shingles, is a viral disease characterized by a painful skin rash with blisters in a localized area. Typically the rash occurs in a single, wide stripe either on the left or right side of the body or face. Two to four days before the rash occurs there may be tingling or local pain in the area. Otherwise there are typically few symptoms though some may have fever, headache, or feel tired. The rash usually heals within two to four weeks; however, some people develop ongoing nerve pain which can last for months or years, a condition called postherpetic neuralgia (PHN). In those with poor immune function the rash may occur widely. If the rash involves the eye, vision loss may occur.
    The Global Info Research report includes an overview of the development of the Herpes Zoster Treatment industry chain, the market status of Hospitals (Oral, Topical), Clinics (Oral, Topical), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Herpes Zoster Treatment.
    Regionally, the report analyzes the Herpes Zoster Treatment markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Herpes Zoster Treatment market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Herpes Zoster Treatment market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Herpes Zoster Treatment industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Oral, Topical).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Herpes Zoster Treatment market.
    Regional Analysis: The report involves examining the Herpes Zoster Treatment market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Herpes Zoster Treatment market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Herpes Zoster Treatment:
    Company Analysis: Report covers individual Herpes Zoster Treatment players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Herpes Zoster Treatment This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinics).
    Technology Analysis: Report covers specific technologies relevant to Herpes Zoster Treatment. It assesses the current state, advancements, and potential future developments in Herpes Zoster Treatment areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Herpes Zoster Treatment market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Herpes Zoster Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
    Market segment by Type
    Oral
    Topical
    Others
    Market segment by Application
    Hospitals
    Clinics
    Home Care Settings
    Market segment by players, this report covers
    Roche
    Novartis
    Merck
    GlaxoSmithKline
    Abbott Laboratories
    Astellas Pharma
    Bausch Health Companies
    Teva Pharmaceutical
    Foamix Pharmaceuticals
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Herpes Zoster Treatment product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Herpes Zoster Treatment, with revenue, gross margin and global market share of Herpes Zoster Treatment from 2019 to 2024.
    Chapter 3, the Herpes Zoster Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Herpes Zoster Treatment market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Herpes Zoster Treatment.
    Chapter 13, to describe Herpes Zoster Treatment research findings and conclusion.

    Buy now